These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 23545236
1. [Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?]. Jean G, Souberbielle JC, Granjon S, Lorriaux C, Hurot JM, Mayor B, Deleaval P, Chazot C. Nephrol Ther; 2013 Jun; 9(3):154-9. PubMed ID: 23545236 [Abstract] [Full Text] [Related]
2. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Delanaye P, Dubois BE, Jouret F, Krzesinski JM, Moranne O, Cavalier E. Clin Chim Acta; 2013 Feb 18; 417():35-8. PubMed ID: 23262367 [Abstract] [Full Text] [Related]
3. Total and bone-specific alkaline phosphatases in haemodialysis patients with chronic liver disease. Jean G, Souberbielle JC, Zaoui E, Lorriaux C, Mayor B, Hurot JM, Deleaval P, Chazot C. Clin Biochem; 2012 Apr 18; 45(6):436-9. PubMed ID: 22314198 [Abstract] [Full Text] [Related]
4. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265 [Abstract] [Full Text] [Related]
5. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Avbersek-Luznik I, Balon BP, Rus I, Marc J. Nephrol Dial Transplant; 2005 Mar 22; 20(3):566-70. PubMed ID: 15665031 [Abstract] [Full Text] [Related]
6. Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort. Jean G, Lafage-Proust MH, Souberbielle JC, Lechevallier S, Deleaval P, Lorriaux C, Hurot JM, Mayor B, Mehdi M, Chazot C. PLoS One; 2018 Mar 22; 13(6):e0199140. PubMed ID: 29912988 [Abstract] [Full Text] [Related]
7. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. Garnero P, Delmas PD. J Clin Endocrinol Metab; 1993 Oct 22; 77(4):1046-53. PubMed ID: 8104954 [Abstract] [Full Text] [Related]
8. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients. Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M. Life Sci; 2012 Jan 30; 90(5-6):212-8. PubMed ID: 22154904 [Abstract] [Full Text] [Related]
9. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L. Kidney Int; 2001 Jul 30; 60(1):257-65. PubMed ID: 11422759 [Abstract] [Full Text] [Related]
14. Correlation between salivary and serum markers of bone turnover in osteopenic rats. Pellegrini GG, Gonzales CM, Somoza JC, Friedman SM, Zeni SN. J Periodontol; 2008 Jan 30; 79(1):158-65. PubMed ID: 18166106 [Abstract] [Full Text] [Related]
15. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM. Am J Kidney Dis; 2016 Apr 30; 67(4):559-66. PubMed ID: 26321176 [Abstract] [Full Text] [Related]
19. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy. Tobiume H, Kanzaki S, Hida S, Ono T, Moriwake T, Yamauchi S, Tanaka H, Seino Y. J Clin Endocrinol Metab; 1997 Jul 30; 82(7):2056-61. PubMed ID: 9215272 [Abstract] [Full Text] [Related]